Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tranexamic acid -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tranexamic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; purified talc; magnesium stearate; colloidal anhydrous silica; povidone; hyprolose; titanium dioxide; macrogol 8000; vanillin; basic butylated methacrylate copolymer - hereditary angioneurotic oedema. short term use in the treatment of hyphaema and in patients with established coagulopathies who are undergoing minor surgery. menorrhagia.

Ireland - English - HPRA (Health Products Regulatory Authority)

pharmacia ireland - tranexamic acid - solution for injection - 500mg/5ml mg/5ml

Ireland - English - HPRA (Health Products Regulatory Authority)

meda health sales ireland limited - tranexamic acid - film coated tablet - 500 milligram - tranexamic acid

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - tranexamic acid - tablet, film coated - 500 mg - tranexamic acid 500 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - tranexamic acid ph. eur. - film-coated tablet - 500 milligram(s) - amino acids; tranexamic acid

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - tranexamic acid - oral tablet - 500mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pfizer laboratories (pty) ltd - injection - see ingredients - each 5 ml solution contains tranexamic acid 500 mg

Canada - English - Health Canada

genmed a division of pfizer canada ulc - tranexamic acid - solution - 100mg - tranexamic acid 100mg - hemostatics